rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-10-30
|
pubmed:abstractText |
The molecular basis of low-dose hyper-radiosensitivity (HRS) is only partially understood. The aim of this study was to define the roles of ataxia telangiectasia mutated (ATM) activity and the downstream ATM-dependent G(2)-phase cell cycle checkpoint in overcoming HRS and triggering radiation resistance.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0360-3016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1262-71
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:17967316-Animals,
pubmed-meshheading:17967316-Cell Cycle Proteins,
pubmed-meshheading:17967316-Cell Line,
pubmed-meshheading:17967316-Cell Survival,
pubmed-meshheading:17967316-Cricetinae,
pubmed-meshheading:17967316-Cricetulus,
pubmed-meshheading:17967316-DNA-Binding Proteins,
pubmed-meshheading:17967316-G2 Phase,
pubmed-meshheading:17967316-Humans,
pubmed-meshheading:17967316-Protein-Serine-Threonine Kinases,
pubmed-meshheading:17967316-RNA, Small Interfering,
pubmed-meshheading:17967316-Radiation Dosage,
pubmed-meshheading:17967316-Radiation Tolerance,
pubmed-meshheading:17967316-Rats,
pubmed-meshheading:17967316-Tumor Suppressor Proteins
|
pubmed:year |
2007
|
pubmed:articleTitle |
Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity.
|
pubmed:affiliation |
Department of Radiation Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|